• 1. Fe3O4@PANI: a magnetic polyaniline nanomaterial for highly efficient and handy enrichment of intact N-glycopeptides??
  Zhizhen Lai,Mo Zhang,Jinyu Zhou,Tianjing Chen,Dan Li,Xuejing Shen,Jia Liu,Jiang Zhou,Zhili Li Analyst, 2021,146, 4261-4267
• 2. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 3. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 4. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 5. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines

Comprehensive Overview of 1,3,5-Trimethyl-3,7-diazabicyclo[3.3.1]nonan-9-ol (CAS No. 169177-17-7)

1,3,5-Trimethyl-3,7-diazabicyclo[3.3.1]nonan-9-ol, identified by its CAS number 169177-17-7, is a structurally unique bicyclic compound that has garnered significant attention in pharmaceutical and chemical research. This molecule features a diazabicyclo[3.3.1]nonane core, which is a privileged scaffold in medicinal chemistry due to its ability to modulate biological targets. The presence of three methyl groups and a hydroxyl group at the 9-position further enhances its versatility in synthetic applications. Researchers are particularly interested in its potential as a chiral building block or ligand for asymmetric catalysis, aligning with the growing demand for enantioselective synthesis in drug development.

In recent years, the compound has been explored for its role in neurological research, where its structural similarity to bioactive alkaloids suggests possible interactions with neurotransmitter receptors. This aligns with the rising interest in central nervous system (CNS) therapeutics, a hot topic in pharmaceutical forums and AI-driven drug discovery platforms. Users frequently search for terms like "novel CNS drug scaffolds" or "nitrogen-containing heterocycles," highlighting the relevance of 169177-17-7 in cutting-edge research. Its low molecular weight and balanced lipophilicity also make it a candidate for optimizing blood-brain barrier permeability, a critical factor in CNS drug design.

The synthesis of 1,3,5-Trimethyl-3,7-diazabicyclo[3.3.1]nonan-9-ol typically involves multi-step organic transformations, including reductive amination and cyclization strategies. A notable challenge is the stereoselective introduction of the hydroxyl group, which has spurred innovations in catalytic asymmetric hydroxylation methods. These advancements resonate with the broader trend toward green chemistry, as researchers seek to minimize waste and improve atom economy. Searches for "sustainable synthesis of bicyclic amines" or "eco-friendly chiral catalysts" reflect this intersection of synthetic efficiency and environmental consciousness.

Beyond pharmaceuticals, CAS 169177-17-7 has potential applications in material science, particularly in the design of smart polymers and coordination complexes. Its rigid bicyclic framework can impart thermal stability to polymers, while the nitrogen atoms enable metal ion chelation—a property leveraged in catalysis and sensor development. This dual applicability addresses frequent queries about "multifunctional organic compounds" and "hybrid organic-inorganic materials," topics trending in academic and industrial circles.

Analytical characterization of this compound relies heavily on NMR spectroscopy and mass spectrometry, with its distinctive fragmentation patterns aiding in structural confirmation. The proton-rich environment of the diazabicyclo core also makes it a model system for studying spin-spin coupling in advanced NMR techniques. Such technical nuances cater to professionals searching for "NMR analysis of polycyclic amines" or "MS interpretation of heterocycles," bridging the gap between theoretical knowledge and practical application.

In summary, 1,3,5-Trimethyl-3,7-diazabicyclo[3.3.1]nonan-9-ol (169177-17-7) exemplifies the convergence of synthetic innovation and interdisciplinary utility. Its relevance to drug discovery, sustainable chemistry, and advanced materials ensures its continued prominence in scientific discourse, answering the call for compounds that push the boundaries of molecular design.

• 373603-88-4(3,3-Dimethylpiperidin-4-ol)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)